Answers are grounded in this paper and cite their sources.
BeatProfiler provides a new machine learning-based approach for multimodal in vitro analysis of cardiac function, disease classification, and drug response.
We anticipate that the capabilities of BeatProfiler will help advance in vitro studies in cardiac biology through rapid phenotyping, revealing mechanisms underlying cardiac health and disease, and enabling objective classification of cardiac disease and responses to drugs.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: